Brims et al reported a model for predicting mortality in a patient with pleural malignant mesothelioma. The authors are from multiple institutions in Australia.
Patient selection: pleural malignant mesothelioma
Analysis: decision tree
Parameters:
(1) weight loss
(2) hemoglobin in g/L
(3) serum albumin in g/L
(4) histology
(5) ECOG performance status
Weight Loss |
Hemoglobin |
Albumin |
Histology |
ECOG |
Group |
no |
< 121 |
NA |
NA |
NA |
4b |
no |
121 - 153 |
NA |
epithelioid |
NA |
2a |
no |
121 - 153 |
NA |
biphasic, sarcomatoid |
NA |
4a |
no |
> 153 |
> 43 |
NA |
NA |
1 |
no |
> 153 |
<= 43 |
NA |
NA |
2b |
yes |
NA |
NA |
sarcomatoid |
PS 0 or 1 |
4d |
yes |
NA |
NA |
biphasic, epithelioid |
PS 0 or 1 |
3 |
yes |
NA |
NA |
NA |
PS >= 2 |
4c |
Group |
18-Month Survival |
1 |
86.7% |
2a |
51.2% |
2b |
46.6% |
3 |
28.1% |
4a |
11.1% |
4b |
6.9% |
4c |
4.3% |
4d |
0% |
Specialty: Hematology Oncology